Spain and Portugal operate respiratory cell therapy programmes with published registries and long-term follow-up. South Korea provides high-volume, efficient delivery with established COPD protocols and rapid access. Germany maintains rigorous protocols but at premium cost. Mexico and Costa Rica offer cost-effective treatment. For evidence-based protocols and outcome transparency, Spanish and Portuguese centres are preferred; for rapid, affordable access, South Korea offers pragmatic advantages.
COPD cell therapy costs €5,000–7,500 per protocol in specialised respiratory centres. Intravenous MSC infusion (€5,500–6,500) is standard. Inhaled exosome therapy (€4,500–5,500) is emerging and may be more cost-effective. Multiple infusions (2–4 over 6 months) increase total cost to €10,000–25,000. Concomitant conventional COPD management (medications, pulmonary rehabilitation) is mandatory and separately funded. Insurance coverage is rare; a few European countries (Spain, Portugal) selectively reimburse for severe COPD (GOLD grade III–IV) with significant disability and failed optimised conventional therapy.
我是候选人吗？ → · COPD & Lung Disease: full overview → · 慢性阻塞性肺病和肺部疾病成本 → · Cost →
由 StemCellAtlas 的编辑团队进行医学审查，与the Stem Plus medical team (physicians & scientists · GMP-certified Sofia laboratory · 25+ yrs international experience) 合作诊所 Stem Plus（索菲亚）的，根据 ISSCR、FDA 和 EMA 指南。 Educational information, not medical advice; figures indicative.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估